Crosstalk between Smad2/3 and specific isoforms of ERK in TGF-β1-induced TIMP-3 expression in rat chondrocytes
Yanhui Zhu1, Jianhua Gu1, Tong Zhu1
1Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Abstract:
This study investigated the roles of ERK1 and ERK2 in transforming growth factor-β1 (TGF-β1)-induced tissue inhibitor of metalloproteinases-3 (TIMP-3) expression in rat chondrocytes, and the specific roles of ERK1 and ERK2 in crosstalk with Smad2/3 were investigated to demonstrate the molecular mechanism of ERK1/2 regulation of TGF-β1 signalling. To examine the interaction of specific isoforms of ERK and the Smad2/3 signalling pathway, chondrocytes were infected with LV expressing either ERK1 or ERK2 siRNA and stimulated with or without TGF-β1. At indicated time-points, TIMP-3 expression was determined by real-time PCR and Western blotting; p-Smad3, nuclear p-Smad3, Smad2/3, p-ERK1/2 and ERK1/2 levels were assessed. And then, aggrecan, type II collagen and the intensity of matrix were examined. TGF-β1-induced TIMP-3 expression was significantly inhibited by ERK1 knock-down, and the decrease in TIMP-3 expression was accompanied by a reduction of p-Smad3 in ERK1 knock-down cells. Knock-down of ERK2 had no effect on neither TGF-β1-induced TIMP-3 expression nor the quantity of p-Smad3. Moreover, aggrecan, type II collagen expression and the intensity of matrix were significantly suppressed by ERK1 knock-down instead of ERK2 knock-down. Taken together, ERK1 and ERK2 have different roles in TGF-β1-induced TIMP-3 expression in rat chondrocytes. ERK1 instead of ERK2 can regulate TGF-β/Smad signalling, which may be the mechanism through which ERK1 regulates TGF-β1-induced TIMP-3 expression.
Insights
Extracellular signal-regulated kinases (ERK1/2) play distinct roles in chondrocyte response to transforming growth factor-β1 (TGF-β1). ERK1, not ERK2, regulates TGF-β1-induced tissue inhibitor of metalloproteinases-3 (TIMP-3) expression and matrix production.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Transforming growth factor-β1 (TGF-β1) is crucial for chondrocyte function and extracellular matrix (ECM) homeostasis.
- Dysregulation of TGF-β1 signaling contributes to cartilage degradation in osteoarthritis.
- Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an important regulator of matrix metalloproteinases (MMPs) and ECM integrity.
Purpose of the Study:
- To elucidate the specific roles of ERK1 and ERK2 in TGF-β1-induced TIMP-3 expression in rat chondrocytes.
- To investigate the molecular mechanism of ERK1/2 regulation of TGF-β1 signaling, focusing on crosstalk with Smad2/3.
- To determine the impact of ERK1 and ERK2 on chondrocyte matrix production.
Main Methods:
- Rat chondrocytes were treated with TGF-β1 and infected with lentiviral vectors expressing ERK1 or ERK2 siRNA.
- TIMP-3 expression was quantified using real-time PCR and Western blotting.
- Levels of phosphorylated Smad3 (p-Smad3), nuclear p-Smad3, Smad2/3, phosphorylated ERK1/2 (p-ERK1/2), and ERK1/2 were assessed.
- Expression of aggrecan, type II collagen, and matrix intensity were examined.
Main Results:
- Knockdown of ERK1 significantly inhibited TGF-β1-induced TIMP-3 expression and reduced p-Smad3 levels.
- Knockdown of ERK2 did not affect TGF-β1-induced TIMP-3 expression or p-Smad3 levels.
- ERK1 knockdown, but not ERK2 knockdown, suppressed aggrecan, type II collagen expression, and matrix intensity.
- ERK1, unlike ERK2, was found to regulate TGF-β/Smad signaling.
Conclusions:
- ERK1 and ERK2 exhibit differential roles in TGF-β1-mediated responses in rat chondrocytes.
- ERK1, but not ERK2, plays a critical role in regulating TGF-β1-induced TIMP-3 expression via the TGF-β/Smad signaling pathway.
- ERK1 is a key mediator of TGF-β1's effects on chondrocyte matrix synthesis and homeostasis.
Related Concept Videos
TGF - β Signaling Pathway
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway


